AZNCF - AstraZeneca PLC (AZN) AstraZeneca to acquire Alexion Conference Call (Transcript)
AstraZeneca PLC (AZN) AstraZeneca to acquire Alexion Conference Call December 12, 2020 09:00 AM ET Company Participants Nick Stone - IR, AstraZeneca Pascal Soriot - CEO, AstraZeneca Marc Dunoyer - CFO, AstraZeneca Mene Pangalos - EVP of BioPharmaceuticals R&D, AstraZeneca Ludwig Hantson - CEO, Alexion Aradhana Sarin - EVP & CFO, Alexion Conference Call Participants James Gordon - JPMorgan Andrew Baum - Citigroup Emmanuel Papadakis - Deutsche Bank Matt Weston - Crédit Suisse Tim Anderson - Wolfe Research Simon Baker - Redburn Sachin Jain - BofA Merrill Lynch Seamus Fernandez - Guggenheim Presentation Nick Stone Pascal, please go ahead. Pascal Soriot Thank you. Welcome, everyone, and thank you very much for joining us for today's webinar. My name is Pascal Soriot. I'm the CEO of AstraZeneca. I apologize we are taking you away from your weekend. But as you can imagine, this is a very material transaction for our company
For further details see:
AstraZeneca PLC (AZN) AstraZeneca to acquire Alexion Conference Call (Transcript)